Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section is reorganized under a general 'Locations' header and now lists Illinois as a study site, replacing the previous 'Illinois Locations' heading. The footer 'HHS Vulnerability Disclosure' link was removed and the revision label updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T13:27:31.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications section now clarifies that entries are automatically filled from PubMed and may not all pertain to the study. A revision tag 'Revision: v3.3.2' is displayed.
    Difference
    0.1%
    Check dated 2025-11-24T21:51:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed a government funding–related notice stating information may not be up to date; study details on the page remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T20:05:01.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Minor formatting tweaks and updates to non-critical metadata were observed, and core study details such as title, NCT number, objectives, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:53.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    2%
    Check dated 2025-10-06T04:25:23.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Expanded immune biology content and updated version to v3.1.0, replacing the previous v3.0.2.
    Difference
    0.7%
    Check dated 2025-09-29T00:58:11.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.